Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Notification Form for Director

Issuer & Securities

Announcement Title: Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer
Date &Time of Broadcast: 21-Feb-2018 17:17:48
Status: New
Announcement Sub Title: Notification Form for Director
Announcement Reference: SG180221OTHRKDL9
Submitted By (Co./ Ind. Name): Dr. Wong Weng Hong
Designation: Chief Executive Officer and Executive Director
Description (Please provide a detailed description of the event in the box below - Refer to the Online help for the format): Please see attached.

This announcement has been prepared by OUE Lippo Healthcare Limited (formerly known as International Healthway Corporation Limited) (the "Company") and its contents have been reviewed by PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"), for compliance with the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this announcement. This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship (Mailing address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: sponsorship@ppcf.com.sg).

Person(s) giving notice: Director/Chief Executive Officer who may also be a substantial shareholder/unitholder (Form 1)
Date of receipt of notice by Listed Issuer: 20/02/2018

if you are unable to view the above file, please click the link below.

Total size =140K